Virbac SA

Paris Stock Exchange VIRP.PA

Virbac SA Price to Earnings Ratio (P/E) on January 14, 2025: 20.44

Virbac SA Price to Earnings Ratio (P/E) is 20.44 on January 14, 2025, a -15.32% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Virbac SA 52-week high Price to Earnings Ratio (P/E) is 28.12 on September 19, 2024, which is 37.59% above the current Price to Earnings Ratio (P/E).
Virbac SA 52-week low Price to Earnings Ratio (P/E) is 20.15 on December 24, 2024, which is -1.40% below the current Price to Earnings Ratio (P/E).
Virbac SA average Price to Earnings Ratio (P/E) for the last 52 weeks is 23.58.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Paris Stock Exchange: VIRP.PA

Virbac SA

CEO	Mr. Habib Ramdani
IPO Date	July 7, 1992
Location	France
Headquarters	13e rue LID - BP 27
Employees	5,459
Sector	Consumer Staples
Industries Pet Food

Description

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Key trends

Past 5 years